MDH1 and cancer: Recently, AC1497 (methyl 3-(3-(4-(2,4,4-trimethylpentan-2-yl)phenoxy)propanamido)benzoate) (Figure 1) was developed as a dual inhibitor of MDH1/2 targeting cancer metabolism [5].